Xerostomia Treatments Market - Global Outlook and Forecast 2022-2028

March 2022 | 63 pages | ID: X62D14AD1611EN
Market Monitor Global

Abstracts

Dry mouth (xerostomia) refers to a condition in which the salivary glands in your mouth don't make enough saliva to keep your mouth wet.

This report contains market size and forecasts of Xerostomia Treatments in Global, including the following market information:

Global Xerostomia Treatments Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Xerostomia Treatments market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Salivary Stimulants Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Xerostomia Treatments include GlaxoSmithKline, Church and Dwight, Hikma Pharmaceuticals, Pendopharm, Parnell Pharmaceuticals and Orahealth, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Xerostomia Treatments companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Xerostomia Treatments Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Xerostomia Treatments Market Segment Percentages, by Type, 2021 (%)

• Salivary Stimulants
• Salivary Substitutes
• Dentifrices

Global Xerostomia Treatments Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Xerostomia Treatments Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies

Global Xerostomia Treatments Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Xerostomia Treatments Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Xerostomia Treatments revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Xerostomia Treatments revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• GlaxoSmithKline
• Church and Dwight
• Hikma Pharmaceuticals
• Pendopharm
• Parnell Pharmaceuticals
• Orahealth

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Xerostomia Treatments Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Xerostomia Treatments Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL XEROSTOMIA TREATMENTS OVERALL MARKET SIZE

2.1 Global Xerostomia Treatments Market Size: 2021 VS 2028
2.2 Global Xerostomia Treatments Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Xerostomia Treatments Players in Global Market
3.2 Top Global Xerostomia Treatments Companies Ranked by Revenue
3.3 Global Xerostomia Treatments Revenue by Companies
3.4 Top 3 and Top 5 Xerostomia Treatments Companies in Global Market, by Revenue in 2021
3.5 Global Companies Xerostomia Treatments Product Type
3.6 Tier 1, Tier 2 and Tier 3 Xerostomia Treatments Players in Global Market
  3.6.1 List of Global Tier 1 Xerostomia Treatments Companies
  3.6.2 List of Global Tier 2 and Tier 3 Xerostomia Treatments Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Xerostomia Treatments Market Size Markets, 2021 & 2028
  4.1.2 Salivary Stimulants
  4.1.3 Salivary Substitutes
  4.1.4 Dentifrices
4.2 By Type - Global Xerostomia Treatments Revenue & Forecasts
  4.2.1 By Type - Global Xerostomia Treatments Revenue, 2017-2022
  4.2.2 By Type - Global Xerostomia Treatments Revenue, 2023-2028
  4.2.3 By Type - Global Xerostomia Treatments Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Xerostomia Treatments Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Online Pharmacies
  5.1.4 Retail Pharmacies
5.2 By Application - Global Xerostomia Treatments Revenue & Forecasts
  5.2.1 By Application - Global Xerostomia Treatments Revenue, 2017-2022
  5.2.2 By Application - Global Xerostomia Treatments Revenue, 2023-2028
  5.2.3 By Application - Global Xerostomia Treatments Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Xerostomia Treatments Market Size, 2021 & 2028
6.2 By Region - Global Xerostomia Treatments Revenue & Forecasts
  6.2.1 By Region - Global Xerostomia Treatments Revenue, 2017-2022
  6.2.2 By Region - Global Xerostomia Treatments Revenue, 2023-2028
  6.2.3 By Region - Global Xerostomia Treatments Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Xerostomia Treatments Revenue, 2017-2028
  6.3.2 US Xerostomia Treatments Market Size, 2017-2028
  6.3.3 Canada Xerostomia Treatments Market Size, 2017-2028
  6.3.4 Mexico Xerostomia Treatments Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Xerostomia Treatments Revenue, 2017-2028
  6.4.2 Germany Xerostomia Treatments Market Size, 2017-2028
  6.4.3 France Xerostomia Treatments Market Size, 2017-2028
  6.4.4 U.K. Xerostomia Treatments Market Size, 2017-2028
  6.4.5 Italy Xerostomia Treatments Market Size, 2017-2028
  6.4.6 Russia Xerostomia Treatments Market Size, 2017-2028
  6.4.7 Nordic Countries Xerostomia Treatments Market Size, 2017-2028
  6.4.8 Benelux Xerostomia Treatments Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Xerostomia Treatments Revenue, 2017-2028
  6.5.2 China Xerostomia Treatments Market Size, 2017-2028
  6.5.3 Japan Xerostomia Treatments Market Size, 2017-2028
  6.5.4 South Korea Xerostomia Treatments Market Size, 2017-2028
  6.5.5 Southeast Asia Xerostomia Treatments Market Size, 2017-2028
  6.5.6 India Xerostomia Treatments Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Xerostomia Treatments Revenue, 2017-2028
  6.6.2 Brazil Xerostomia Treatments Market Size, 2017-2028
  6.6.3 Argentina Xerostomia Treatments Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Xerostomia Treatments Revenue, 2017-2028
  6.7.2 Turkey Xerostomia Treatments Market Size, 2017-2028
  6.7.3 Israel Xerostomia Treatments Market Size, 2017-2028
  6.7.4 Saudi Arabia Xerostomia Treatments Market Size, 2017-2028
  6.7.5 UAE Xerostomia Treatments Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 GlaxoSmithKline
  7.1.1 GlaxoSmithKline Corporate Summary
  7.1.2 GlaxoSmithKline Business Overview
  7.1.3 GlaxoSmithKline Xerostomia Treatments Major Product Offerings
  7.1.4 GlaxoSmithKline Xerostomia Treatments Revenue in Global Market (2017-2022)
  7.1.5 GlaxoSmithKline Key News
7.2 Church and Dwight
  7.2.1 Church and Dwight Corporate Summary
  7.2.2 Church and Dwight Business Overview
  7.2.3 Church and Dwight Xerostomia Treatments Major Product Offerings
  7.2.4 Church and Dwight Xerostomia Treatments Revenue in Global Market (2017-2022)
  7.2.5 Church and Dwight Key News
7.3 Hikma Pharmaceuticals
  7.3.1 Hikma Pharmaceuticals Corporate Summary
  7.3.2 Hikma Pharmaceuticals Business Overview
  7.3.3 Hikma Pharmaceuticals Xerostomia Treatments Major Product Offerings
  7.3.4 Hikma Pharmaceuticals Xerostomia Treatments Revenue in Global Market (2017-2022)
  7.3.5 Hikma Pharmaceuticals Key News
7.4 Pendopharm
  7.4.1 Pendopharm Corporate Summary
  7.4.2 Pendopharm Business Overview
  7.4.3 Pendopharm Xerostomia Treatments Major Product Offerings
  7.4.4 Pendopharm Xerostomia Treatments Revenue in Global Market (2017-2022)
  7.4.5 Pendopharm Key News
7.5 Parnell Pharmaceuticals
  7.5.1 Parnell Pharmaceuticals Corporate Summary
  7.5.2 Parnell Pharmaceuticals Business Overview
  7.5.3 Parnell Pharmaceuticals Xerostomia Treatments Major Product Offerings
  7.5.4 Parnell Pharmaceuticals Xerostomia Treatments Revenue in Global Market (2017-2022)
  7.5.5 Parnell Pharmaceuticals Key News
7.6 Orahealth
  7.6.1 Orahealth Corporate Summary
  7.6.2 Orahealth Business Overview
  7.6.3 Orahealth Xerostomia Treatments Major Product Offerings
  7.6.4 Orahealth Xerostomia Treatments Revenue in Global Market (2017-2022)
  7.6.5 Orahealth Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Xerostomia Treatments Market Opportunities & Trends in Global Market
Table 2. Xerostomia Treatments Market Drivers in Global Market
Table 3. Xerostomia Treatments Market Restraints in Global Market
Table 4. Key Players of Xerostomia Treatments in Global Market
Table 5. Top Xerostomia Treatments Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Xerostomia Treatments Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Xerostomia Treatments Revenue Share by Companies, 2017-2022
Table 8. Global Companies Xerostomia Treatments Product Type
Table 9. List of Global Tier 1 Xerostomia Treatments Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Xerostomia Treatments Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Xerostomia Treatments Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Xerostomia Treatments Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Xerostomia Treatments Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Xerostomia Treatments Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Xerostomia Treatments Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Xerostomia Treatments Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Xerostomia Treatments Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Xerostomia Treatments Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Xerostomia Treatments Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Xerostomia Treatments Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Xerostomia Treatments Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Xerostomia Treatments Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Xerostomia Treatments Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Xerostomia Treatments Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Xerostomia Treatments Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Xerostomia Treatments Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Xerostomia Treatments Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Xerostomia Treatments Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Xerostomia Treatments Revenue, (US$, Mn), 2023-2028
Table 30. GlaxoSmithKline Corporate Summary
Table 31. GlaxoSmithKline Xerostomia Treatments Product Offerings
Table 32. GlaxoSmithKline Xerostomia Treatments Revenue (US$, Mn), (2017-2022)
Table 33. Church and Dwight Corporate Summary
Table 34. Church and Dwight Xerostomia Treatments Product Offerings
Table 35. Church and Dwight Xerostomia Treatments Revenue (US$, Mn), (2017-2022)
Table 36. Hikma Pharmaceuticals Corporate Summary
Table 37. Hikma Pharmaceuticals Xerostomia Treatments Product Offerings
Table 38. Hikma Pharmaceuticals Xerostomia Treatments Revenue (US$, Mn), (2017-2022)
Table 39. Pendopharm Corporate Summary
Table 40. Pendopharm Xerostomia Treatments Product Offerings
Table 41. Pendopharm Xerostomia Treatments Revenue (US$, Mn), (2017-2022)
Table 42. Parnell Pharmaceuticals Corporate Summary
Table 43. Parnell Pharmaceuticals Xerostomia Treatments Product Offerings
Table 44. Parnell Pharmaceuticals Xerostomia Treatments Revenue (US$, Mn), (2017-2022)
Table 45. Orahealth Corporate Summary
Table 46. Orahealth Xerostomia Treatments Product Offerings
Table 47. Orahealth Xerostomia Treatments Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Xerostomia Treatments Segment by Type in 2021
Figure 2. Xerostomia Treatments Segment by Application in 2021
Figure 3. Global Xerostomia Treatments Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Xerostomia Treatments Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Xerostomia Treatments Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Xerostomia Treatments Revenue in 2021
Figure 8. By Type - Global Xerostomia Treatments Revenue Market Share, 2017-2028
Figure 9. By Application - Global Xerostomia Treatments Revenue Market Share, 2017-2028
Figure 10. By Region - Global Xerostomia Treatments Revenue Market Share, 2017-2028
Figure 11. By Country - North America Xerostomia Treatments Revenue Market Share, 2017-2028
Figure 12. US Xerostomia Treatments Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Xerostomia Treatments Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Xerostomia Treatments Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Xerostomia Treatments Revenue Market Share, 2017-2028
Figure 16. Germany Xerostomia Treatments Revenue, (US$, Mn), 2017-2028
Figure 17. France Xerostomia Treatments Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Xerostomia Treatments Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Xerostomia Treatments Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Xerostomia Treatments Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Xerostomia Treatments Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Xerostomia Treatments Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Xerostomia Treatments Revenue Market Share, 2017-2028
Figure 24. China Xerostomia Treatments Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Xerostomia Treatments Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Xerostomia Treatments Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Xerostomia Treatments Revenue, (US$, Mn), 2017-2028
Figure 28. India Xerostomia Treatments Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Xerostomia Treatments Revenue Market Share, 2017-2028
Figure 30. Brazil Xerostomia Treatments Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Xerostomia Treatments Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Xerostomia Treatments Revenue Market Share, 2017-2028
Figure 33. Turkey Xerostomia Treatments Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Xerostomia Treatments Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Xerostomia Treatments Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Xerostomia Treatments Revenue, (US$, Mn), 2017-2028
Figure 37. GlaxoSmithKline Xerostomia Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Church and Dwight Xerostomia Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Hikma Pharmaceuticals Xerostomia Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Pendopharm Xerostomia Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Parnell Pharmaceuticals Xerostomia Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Orahealth Xerostomia Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)